BRPI1016082A2 - formulação de selante intramamário de mamilo e método de usar o mesmo para reduzir ou eliminar defeitos visuais em queijos envelhecidos - Google Patents

formulação de selante intramamário de mamilo e método de usar o mesmo para reduzir ou eliminar defeitos visuais em queijos envelhecidos

Info

Publication number
BRPI1016082A2
BRPI1016082A2 BRPI1016082A BRPI1016082A BRPI1016082A2 BR PI1016082 A2 BRPI1016082 A2 BR PI1016082A2 BR PI1016082 A BRPI1016082 A BR PI1016082A BR PI1016082 A BRPI1016082 A BR PI1016082A BR PI1016082 A2 BRPI1016082 A2 BR PI1016082A2
Authority
BR
Brazil
Prior art keywords
intramammary
nipple
reduce
visual defects
sealant formulation
Prior art date
Application number
BRPI1016082A
Other languages
English (en)
Inventor
A Rankin Scott
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42154514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1016082(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of BRPI1016082A2 publication Critical patent/BRPI1016082A2/pt
Publication of BRPI1016082B1 publication Critical patent/BRPI1016082B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI1016082-5A 2009-04-08 2010-04-07 selante intramamário de mamilos BRPI1016082B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20787909P 2009-04-08 2009-04-08
US61/207,879 2009-04-08
PCT/US2010/030252 WO2010118142A1 (en) 2009-04-08 2010-04-07 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses

Publications (2)

Publication Number Publication Date
BRPI1016082A2 true BRPI1016082A2 (pt) 2017-07-18
BRPI1016082B1 BRPI1016082B1 (pt) 2020-12-22

Family

ID=42154514

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1016082-5A BRPI1016082B1 (pt) 2009-04-08 2010-04-07 selante intramamário de mamilos

Country Status (14)

Country Link
US (2) US9956167B2 (pt)
EP (1) EP2416787B1 (pt)
JP (2) JP5773983B2 (pt)
KR (1) KR20120005497A (pt)
CN (1) CN102802642A (pt)
AU (1) AU2010234514B2 (pt)
BR (1) BRPI1016082B1 (pt)
CA (1) CA2757471A1 (pt)
CO (1) CO6450660A2 (pt)
MX (1) MX2011010603A (pt)
NZ (1) NZ595229A (pt)
UA (1) UA106226C2 (pt)
WO (1) WO2010118142A1 (pt)
ZA (2) ZA201107181B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1016082B1 (pt) * 2009-04-08 2020-12-22 Wisconsin Alumni Research Foundation selante intramamário de mamilos
CN104644670B (zh) * 2015-02-26 2017-12-19 齐鲁动物保健品有限公司 用于预防奶牛干乳期乳房炎的乳头封闭剂及其制备方法
CN105056077A (zh) * 2015-09-07 2015-11-18 陈红 一种治疗功能性消化不良的中药组合物
EP3634378A1 (en) * 2017-06-09 2020-04-15 Zoetis Broomhill IP Limited Intramammary veterinary composition
JP2021511113A (ja) * 2018-01-18 2021-05-06 ゾエティス・ブルームヒル・アイピー・リミテッド 乾乳牛のウシ乳房炎予防における内部ティートシールおよびその使用
GR1010072B (el) * 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους
CN111840212B (zh) * 2020-06-18 2023-07-21 余祖功 一种非人类动物用乳头封闭剂及其制备方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2249523A (en) * 1939-03-31 1941-07-15 Eastman Kodak Co Medicament
US2713020A (en) * 1953-10-21 1955-07-12 Bristol Lab Inc Repository bismuth subsalicylate
US2772198A (en) 1954-11-08 1956-11-27 Standard Oil Co Method of killing flies with composition comprising pyrethrins and p-aminoazobenzene
US2921853A (en) 1957-03-04 1960-01-19 Northern Trust Co Flavor premix for animal feeds
NL103467C (pt) 1959-05-12
US3137623A (en) 1960-08-02 1964-06-16 Geigy Chem Corp Dermatological preparations comprising a corticosteroid and crotonic acid-nu-ethyl-omicron-toluidide
US3252859A (en) * 1962-10-24 1966-05-24 Masti Kure Company Inc Colloidal silica-oil composition and method of using same
US3222252A (en) * 1962-11-01 1965-12-07 Heinz J Kraus Preparation and method for the prevention, treatment, and control of mastitis in bovine udders
US3210248A (en) 1963-09-04 1965-10-05 Merck & Co Inc Emollient gel comprising lanolin alcohol, microcrystalline wax and a liqquid fatty acid ester
US3326808A (en) 1965-08-25 1967-06-20 Pfizer & Co C Antiseptic detergent composition
US3535419A (en) * 1965-12-15 1970-10-20 Syntex Corp Veterinary compositions and methods
US3535427A (en) 1969-02-19 1970-10-20 Frosst & Co Charles E Skin moisturizing concentrate containing lanolin derivatives
US3597415A (en) * 1969-05-14 1971-08-03 Upjohn Co Erythromycin amides and process for preparing same
US3728449A (en) 1972-05-01 1973-04-17 West Laboratories Inc Germicidal iodine compositions for application to skin tissue including teats of milk animals
GB1441747A (en) 1972-10-18 1976-07-07 Lazonby B Veterinary compositions
GB1455296A (en) 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
US4034099A (en) 1974-03-29 1977-07-05 The Upjohn Company Compositions and method for treating mastitis in milk animals
CA1052697A (en) * 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
US4049830A (en) 1974-11-13 1977-09-20 Milmark Research, Inc. Bovine teat dip
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
US4140766A (en) 1977-10-25 1979-02-20 Kalogris Theodore P Method and composition for therapy and control of bovine mastitis
US4199602A (en) 1978-02-23 1980-04-22 Economics Laboratory, Inc. Control of mastitis and compositions therefor
US4258056A (en) 1978-12-18 1981-03-24 Economics Laboratory, Inc. Control of mastitis and compositions therefor
US4308859A (en) * 1979-08-01 1982-01-05 Child Laboratories Inc. Method of inhibiting mastitis in bovine animals
US4344967A (en) 1979-08-07 1982-08-17 Devro, Inc. Film forming composition and uses thereof
EP0081325A3 (en) 1981-12-09 1984-05-23 Beecham Group Plc Antibacterial compounds
US4401666A (en) 1982-02-01 1983-08-30 Olin Corporation Use of metallic salts of pyridine-2-thione-N-oxide to treat or prevent bovine mastitis
US4610993A (en) 1984-08-08 1986-09-09 Olin Corporation Use of selected pyridine-N-oxide disulfide compounds to treat or prevent bovine mastitis
ES8601148A1 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
GB8629481D0 (en) * 1986-12-10 1987-01-21 Beecham Group Plc Veterinary treatment
JPS63203628A (ja) 1987-02-19 1988-08-23 Taiyo Kagaku Co Ltd 動物の乳房炎治療剤
US4804530A (en) 1987-07-17 1989-02-14 The Procter & Gamble Company Anaerobe-selective antibacterial compositions and methods
JPH01294609A (ja) 1988-02-09 1989-11-28 Toyo Kagaku Kenkyusho:Kk 歯科用根管充填用シーラー
JPH0352691A (ja) 1989-07-20 1991-03-06 Iwao Takano 酸含有水
WO1994013261A1 (en) 1992-12-08 1994-06-23 Bimeda Research And Development Limited Aqueous antibiotic composition for veterinary use
DE4402544C2 (de) 1994-01-28 1996-01-18 Chevita Gmbh Veterinärmedizinische Verwendung von Calciumformiat in Gel- oder Pastenform
IL126489A0 (en) 1996-06-20 1999-08-17 Novartis Ag Method for the prevention and treatment of mastitis
GB2334886B (en) * 1996-12-18 2000-08-23 Bimeda Res Dev Ltd Antiinfective free intramammary veterinary composition
US6433068B1 (en) 1997-03-07 2002-08-13 David S. Morrison Hydrocarbon gels as suspending and dispersing agents and products
US6749869B1 (en) * 1997-09-26 2004-06-15 Ecolab Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection
CA2225352C (en) * 1998-01-30 2003-10-21 Nam Fong Han Vegetable derived petroleum jelly replacement
WO2000026285A1 (en) 1998-10-29 2000-05-11 Penreco Gel compositions
US6183785B1 (en) 1998-11-12 2001-02-06 Geoffrey J. Westfall Teat disinfectant
JP4241041B2 (ja) * 2000-12-07 2009-03-18 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸分解性活性成分を含有するペースト形の医薬品製造物
KR100474945B1 (ko) 2002-01-10 2005-03-10 알앤엘생명과학주식회사 젖소의 원유 중 체세포 감소용 및 유방염의 예방 또는치료용 조성물
AUPS080802A0 (en) * 2002-02-27 2002-03-21 Advanced Powder Technology Pty Ltd A zinc oxide powder for use in a sunscreen composition
US20040197422A1 (en) * 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis
US7087190B2 (en) 2003-03-20 2006-08-08 Ecolab Inc. Composition for the production of chlorine dioxide using non-iodo interhalides or polyhalides and methods of making and using the same
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
US20060094777A1 (en) * 2004-11-01 2006-05-04 Westfall Geoffrey J Teat disinfectant having zinc EDTA, and methods
US20070027119A1 (en) * 2005-07-29 2007-02-01 Ahmed Fahim U Antibacterial composition and method of use
NZ549249A (en) * 2006-08-18 2009-10-30 Univ Massey Methods for reducing the incidence of mastitis by administration of keratin
WO2008045920A2 (en) * 2006-10-10 2008-04-17 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
NZ571347A (en) * 2008-09-17 2010-04-30 Mastitis Res Ct Ltd Anti-infective formulation and methods of use
EP3158868A1 (en) * 2008-12-04 2017-04-26 Merial, Inc Intramammary teat sealant
BRPI1016082B1 (pt) * 2009-04-08 2020-12-22 Wisconsin Alumni Research Foundation selante intramamário de mamilos

Also Published As

Publication number Publication date
JP6022634B2 (ja) 2016-11-09
WO2010118142A1 (en) 2010-10-14
JP5773983B2 (ja) 2015-09-02
US20180207090A1 (en) 2018-07-26
CA2757471A1 (en) 2010-10-14
KR20120005497A (ko) 2012-01-16
UA106226C2 (ru) 2014-08-11
JP2015134818A (ja) 2015-07-27
AU2010234514B2 (en) 2014-03-27
CN102802642A (zh) 2012-11-28
US10744085B2 (en) 2020-08-18
US20100266708A1 (en) 2010-10-21
EP2416787A1 (en) 2012-02-15
CO6450660A2 (es) 2012-05-31
EP2416787B1 (en) 2015-10-21
MX2011010603A (es) 2011-12-08
US9956167B2 (en) 2018-05-01
ZA201107181B (en) 2012-12-27
JP2012523423A (ja) 2012-10-04
NZ595229A (en) 2012-08-31
BRPI1016082B1 (pt) 2020-12-22
AU2010234514A1 (en) 2011-10-13
ZA201207324B (en) 2013-06-26

Similar Documents

Publication Publication Date Title
ZA200902544B (en) Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
CU24154B1 (es) Método e instalación de tratamiento de agua para ser utilizada en procesos industriales
FI20135627L (fi) Menetelmä ja väline jätteenkäsittelyssä
PL2534332T3 (pl) System i sposób ultradźwiękowej obróbki cieczy w odwiertach i odpowiednie stosowanie tego systemu
PT2637465E (pt) Método e aparelho para informar o estado do buffer
ZA201503332B (en) Water treatment composition and method of using same
FI20095554L (fi) Menetelmä ja väline jätteenkäsittelyssä
ZA201201438B (en) Injectable aqueous ophthalmic composition and method of use therefor
BR112013000321A2 (pt) aparelho para uma cortina e painel de barreira de contenção para utilização em água e método de fabricação de uma cortina de barreira de contenção para utilização em água
FI20116074L (fi) Nestemäinen entsyymivalmiste ja menetelmä sen valmistamiseksi
BR112014014213A2 (pt) agentes hemostáticos e método de utilização
EP2750705A4 (en) METHOD FOR THE EFFECTIVE AND FAST DESENSIBILIZATION OF ALLERGY PATIENTS
BR112012031487A2 (pt) processo para a produção de uma emulsão em água, emulsão de óleo em água, composição imunogênica, uso de uma emulsão de óleo em água ou da composição imunogênica,método de tratamento,e,kit
IL229381B (en) Brilacitidine and its results for use in the treatment of mucositis
PT2613798E (pt) Utilização de lipase ácida lisossomal para o tratamento da deficiência de lipase ácida lisossomal em doentes
ZA201207324B (en) Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
BR112013009578A2 (pt) composição tópica em gel e método
EP2665794A1 (en) Families of scale-inhibitors having different absorption profiles and their application in oilfield
ZA201304353B (en) Remedial composition and treatment methods
BR112013009577A2 (pt) composição de gel tópico e método
IL219225A0 (en) Ophthalmic formulation and method of manufacture thereof
BR112013008447A2 (pt) ''cdomposição de limpeza liquida e método''
EE201000096A (et) Meetod nanokolloidse SnO2 veesooli valmistamiseks ja selle kasutamine
BR112012019763A2 (pt) método e aparelho para ajustar a concentração de ácidos ou lixívias
HK1162922A (en) Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2769 DE 30-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.